Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Friday, November 22, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Nayax Launches Self-Service in El Salvador, Expands
ADDMAN and Continuous Composites Advance 3D Printing
Virtualitics Wins Phase III SBIR Contract for USAF Solution
Myers Industries Appoints Aaron Schapper as CEO
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
Avutometinib
Avutometinib
Biotechnology
Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer
News Desk
-
July 30, 2024
Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Nayax Launches Self-Service in El Salvador, Expands
ADDMAN and Continuous Composites Advance 3D Printing
Virtualitics Wins Phase III SBIR Contract for USAF Solution
Load more
